Qty	Catalog Number	Ordering Description	Qty/Pack	List Price
			96-Well Plate

Qty	Catalog Number	Ordering Description	Qty/Pack	List Price
	48-602MAG	Buffer Detection Kit for Magnetic Beads	1 Kit

EQCYTMAG-93K MilliporeMILLIPLEX MAP Equine Cytokine/Chemokine Magnetic Bead Panel - Immunology Multiplex Assay

The Equine Inflammation / Immunology Bead-Based Multiplex cytokine Assay kit, using the Luminex xMAP technology, enables the simultaneous analysis of 23 cytokine and chemokine biomarkers in equine serum, plasma and cell culture samples.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

SDS
Brochures
Technical Information
Protocols

Key Applications: Multiplexing Detection Methods: Luminex xMAP Research Category: Inflammation & Immunology

Recommended Products

Overview

Replacement Information

Special Offers

This panel is available for custom premix. Talk to your Protein Specialist today!

Key Specifications Table

Analytes Available	Species Reactivity	Key Applications	Detection Methods
Eotaxin/CCL11 FGF-2 Fractalkine/CX3CL1 G-CSF GM-CSF GRO/KC IFN-γ IL-1α IL-1β IL-2 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 (p70) IL-13 IL-17A IL-18 IP-10 MCP-1 RANTES TNF-α	Eq	Mplex	Luminex xMAP

Description
Catalogue Number	EQCYTMAG-93K
Trade Name	MILLIPLEX
Description	MILLIPLEX MAP Equine Cytokine/Chemokine Magnetic Bead Panel - Immunology Multiplex Assay
Overview	EMD Millipore’s MILLIPLEX® MAP Equine Cytokine Magnetic Bead Panel is a 23-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma or culture supernatant samples: Eotaxin/CCL11, FGF-2. Fractalkine/CS3CL1, G-CSF, GM-CSF, GRO, IFN, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8/CXCL8, IL-10, IL-12 (p70), IL-13, IL-17a, IL-18, IP-10, MCP-1, RANTES/CCL5 and TNFα. MILLIPLEX® MAP offers the broadest selection of analytes across a wide range of disease states and species. Once the analytes of interest have been identified, you can rely on the quality that we build into each kit to produce results you can trust. In addition to the assay characteristics listed in the protocol, other performance criteria evaluated during the validation process include: cross-reactivity, dilution linearity, kit stability, and sample behavior (e.g. detectability and stability). Each panel and kit meets stringent manufacturing criteria to ensure batch-to-batch reproducibility. Each MILLIPLEX® MAP panel and kit includes: - Quality controls (QCs) provided to qualify assay performance - Comparison of standard (calibrator) and QC lots to a reference lot to ensure lot-to-lot consistency - Optimized serum matrix to mimic native analyte environment - Detection antibody cocktails designed to yield consistent analyte profiles within panel EMD Millipore’s MILLIPLEX® MAP Equine Cytokine Magnetic Bead Panel is part of the most versatile system available for cytokine research. From our single to multiplex biomarker solutions, we partner with you to design, develop, analytically validate and build the most comprehensive library available for protein detection and quantitation.
Background Information	Inflammation and immune cell response are key to maintaining homeostasis. The more we understand the mechanisms of disease, the more we discover the role that inflammation plays in the etiology of disease. This is a true for horses as it is for humans. Both experience immunological diseases, such as infectious disease, osteoarthritis and respiratory disease, as well as neurologic, metabolic and cardiovascular disease and even cancer. However, until now the ability to measure levels of cytokines and chemokine in horses has been limited primarily to ELISAs. However, researchers will now the ability to measure multiple inflammation biomarkers simultaneously using EMD Millipore’s MILLIPLEX® MAP Equine Cytokine/Chemokine Panel, based on the Luminex xMAP® technology.

References

Product Information
Detection method	Luminex xMAP
Configuration	Design your multiplex kit by choosing available analytes within this panel.
Precision, %	Inter-assay: <20 Intra-assay: <10
Panel Type	MAGNETIC Cytokines/Chemokines
Quality Level	MQ200

Applications
Application	The Equine Inflammation / Immunology Bead-Based Multiplex cytokine Assay kit, using the Luminex xMAP technology, enables the simultaneous analysis of 23 cytokine and chemokine biomarkers in equine serum, plasma and cell culture samples.
Key Applications	Multiplexing
Application Notes	• This is an overnight (16-18 hours at 2-8 °C) or two-hour (20-25°C) incubation assay; although an overnight incubation is recommended. • A maximum of 25 µL per well of neat serum or plasma can be used. Tissue culture supernatant may require a dilution with an appropriate control medium prior to assay. • This kit may be used for the analysis of all or any combination of the Equine Cytokine/Chemokine Panel analytes in serum, plasma or tissue/cell/tumor culture supernatant.

Biological Information
Specificity	Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.
Species Reactivity	Horse
Analytes Available	Eotaxin/CCL11 FGF-2 Fractalkine/CX3CL1 G-CSF GM-CSF GRO/KC IFN-γ IL-1α IL-1β IL-2 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 (p70) IL-13 IL-17A IL-18 IP-10 MCP-1 RANTES TNF-α
Cross Reactivity	Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.
Accuracy	Eotaxin/CCL11: 93% FGF-2: 78% Fractalkine/CS3CL1: 91% G-CSF: 82% GM-CSF: 92% GRO: 97% IFNγ: 83% IL-1α: 89% IL-1β: 88% IL-2: 90% IL-4: 91% IL-5: 92% IL-6: 76% IL-8/CXCL8: 89% IL-10: 86% IL-12 (p70): 83% IL-13: 85% IL-17a: 74% IL-18: 94% IP-10: 86% MCP-1: 90% RANTES/CCL5: 88% TNFα: 87%

Physicochemical Information
Sensitivity	Eotaxin/CCL11: 8.3 pg/mL FGF-2: 16.3 pg/mL Fractalkine/CS3CL1: 457 pg/mL G-CSF: 340 pg/mL GM-CSF: 3.94 pg/mL GRO: 7.8 pg/mL IFNγ: 165 pg/mL IL-1α: 39.1 pg/mL IL-1β: 29.3 pg/mL IL-2: 13.5 pg/mL IL-4: 355 pg/mL IL-5: 10.6 pg/mL IL-6: 1.4 pg/mL IL-8/CXCL8: 74.3 pg/mL IL-10: 62.5 pg/mL IL-12 (p70): 49.2 pg/mL IL-13: 39 – 130 pg/mL IL-17A: 15.4 pg/mL IL-18: 25.3 pg/mL IP-10: 16.7 pg/mL MCP-1: 399 ng/mL RANTES/CCL5: 3.9 pg/mL TNFα: 5.2 pg/mL
Standard Curve Range	Eotaxin/CCL11: 8.3 pg/mL FGF-2: 16.3 pg/mL Fractalkine/CS3CL1: 457 pg/mL G-CSF: 340 pg/mL GM-CSF: 5 – 5,000 pg/mL GRO: 6 – 6,000 pg/mL IFNγ: 488 – 500,000 pg/mL IL-1α: 59 – 60,000 pg/mL IL-1β: 29 – 30,000 pg/mL IL-2: 15 – 15,000 pg/mL IL-4: 293 – 300,000 pg/mL IL-5: 15 – 15,000 pg/mL IL-6: 15 – 15,000 pg/mL IL-8/CXCL8: 59 – 60,000 pg/mL IL-10: 49 – 50,000 pg/mL IL-12 (p70): 39- 40,000 pg/mL IL-13: 39 – 40,000 pg/mL IL-17A: 15 – 15,000 pg/mL IL-18: 34 – 35,000 pg/mL IP-10: 15 – 15,000 pg/mL MCP-1: 342 – 350,000 ng/mL RANTES/CCL5: 5 – 5,000 pg/mL TNFα: 4 - 4,000 pg/mL

Physicochemical Information

Sensitivity

Eotaxin/CCL11: 8.3 pg/mL
FGF-2: 16.3 pg/mL
Fractalkine/CS3CL1: 457 pg/mL
G-CSF: 340 pg/mL
GM-CSF: 3.94 pg/mL
GRO: 7.8 pg/mL
IFNγ: 165 pg/mL
IL-1α: 39.1 pg/mL
IL-1β: 29.3 pg/mL
IL-2: 13.5 pg/mL
IL-4: 355 pg/mL
IL-5: 10.6 pg/mL
IL-6: 1.4 pg/mL
IL-8/CXCL8: 74.3 pg/mL
IL-10: 62.5 pg/mL
IL-12 (p70): 49.2 pg/mL
IL-13: 39 – 130 pg/mL
IL-17A: 15.4 pg/mL
IL-18: 25.3 pg/mL
IP-10: 16.7 pg/mL
MCP-1: 399 ng/mL
RANTES/CCL5: 3.9 pg/mL
TNFα: 5.2 pg/mL

Standard Curve Range

Eotaxin/CCL11: 8.3 pg/mL
FGF-2: 16.3 pg/mL
Fractalkine/CS3CL1: 457 pg/mL
G-CSF: 340 pg/mL
GM-CSF: 5 – 5,000 pg/mL
GRO: 6 – 6,000 pg/mL
IFNγ: 488 – 500,000 pg/mL
IL-1α: 59 – 60,000 pg/mL
IL-1β: 29 – 30,000 pg/mL
IL-2: 15 – 15,000 pg/mL
IL-4: 293 – 300,000 pg/mL
IL-5: 15 – 15,000 pg/mL
IL-6: 15 – 15,000 pg/mL
IL-8/CXCL8: 59 – 60,000 pg/mL
IL-10: 49 – 50,000 pg/mL
IL-12 (p70): 39- 40,000 pg/mL
IL-13: 39 – 40,000 pg/mL
IL-17A: 15 – 15,000 pg/mL
IL-18: 34 – 35,000 pg/mL
IP-10: 15 – 15,000 pg/mL
MCP-1: 342 – 350,000 ng/mL
RANTES/CCL5: 5 – 5,000 pg/mL
TNFα: 4 - 4,000 pg/mL

Dimensions

Materials Information

Toxicological Information

Safety Information according to GHS

Safety Information

Product Usage Statements
Usage Statement	Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Storage and Shipping Information
Storage Conditions	Recommended storage for kit components is 2 - 8°C.

Packaging Information
Material Size	96-well plate
Material Package	96 well plate

Transport Information

Supplemental Information

Specifications

Global Trade Item Number
Catalog Number	GTIN
EQCYTMAG-93K	04055977350111

Documentation

Protocols

Title
Protocol- EQCYTMAG-93K

MILLIPLEX MAP Equine Cytokine/Chemokine Magnetic Bead Panel - Immunology Multiplex Assay SDS

Title
Safety Data Sheet (SDS)

Brochure

Title
A closer look at immunoassay platforms: Beyond fit for purpose
Custom Immunoassay Menu of Services

Technical Info

Title
96 well Template 2 Up
96 well Template Single
Quality Control Range Sheet- CYT-107 and CYT-207
Quality Control Range Sheet- CYT-108 and CYT-208
Quality Control Ranges: Milliplex® MAP Equine Cytokine/Chemokine Magnetic Bead Panel

Related Products & Applications

Related Products

Catalog Number	Description
EQCTMG93KPX23BK	MILLIPLEX MAP Equine Cytokine/Chemokine Magnetic Bead Panel Premix Space Saver (Bulk) Packaging
EQCYTMG-93KPX23	MILLIPLEX MAP Equine Cytokine/Chemokine Magnetic Bead Panel Premixed 23-Plex Panel - Immunology Multiplex Assay

The Product Has Been Added To Your Cart